Market Closed

DMAC
DiaMedica Therapeutics
$ 8.79
-5.79%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

DiaMedica Therapeutics News

Latest DiaMedica Therapeutics Stock News & DMAC Headlines

DiaMedica Therapeutics Inc. (DMAC) Q3 2026 Earnings Call Transcript
2 days ago | seekingalpha.com
DiaMedica Therapeutics Q3 Earnings Call Highlights
2 days ago | marketbeat.com
DiaMedica Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
2 days ago | businesswire.com
DiaMedica Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Business Update November 13, 2026
10 days ago | businesswire.com
DiaMedica Therapeutics Announces Enrollment of 200th Patient in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
24 days ago | gurufocus.com
DiaMedica Therapeutics Provides Update on Fetal Growth Restriction Key Opinion Leader Webinar
a month ago | businesswire.com
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR Results
2 months ago | businesswire.com
DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences
2 months ago | gurufocus.com
DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences
2 months ago | businesswire.com
Wall Street Analysts Think DiaMedica Therapeutics (DMAC) Could Surge 129.97%: Read This Before Placing a Bet
3 months ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

DMAC
DiaMedica Therapeutics
$ 8.79
-5.79%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago